Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Name: Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication
SKU: 4168
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 41 No. 1 Articles Tags: brain-imaging, dick-veltman, dopaminergic-manipulation, fabiana-da-silva-alves, fmri, martijn-figee, md, ms, negative-symptoms, phd, phmri, prefrontal-hypoactivity, schizophrenia-patients, schizophrenia-treatment, subcortical-hyperactivity, therese-van-amelsvoort, work-memory

Description

Description

Fabiana da Silva Alves, MS

BRAIN IMAGING

The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Fabiana da Silva Alves, MS, Martijn Figee, MD, Therese van Amelsvoort, MD, PhD, Dick Veltman, MD, PhD, and Lieuwe de Haan, MD, PhD

PB-41-1-09-Alves

Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Description

Fabiana da Silva Alves, MS

BRAIN IMAGING

The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Fabiana da Silva Alves, MS, Martijn Figee, MD, Therese van Amelsvoort, MD, PhD, Dick Veltman, MD, PhD, and Lieuwe de Haan, MD, PhD

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Ellen B. Dennehy, PhD: Concordance with Treatment Guidelines for Bipolar Disorder: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Description

Fabiana da Silva Alves, MS

BRAIN IMAGING

The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Fabiana da Silva Alves, MS, Martijn Figee, MD, Therese van Amelsvoort, MD, PhD, Dick Veltman, MD, PhD, and Lieuwe de Haan, MD, PhD

Related products

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Ellen B. Dennehy, PhD: Concordance with Treatment Guidelines for Bipolar Disorder: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial